ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

NIH To Sponsor Animal Care, Human Protection Workshop

February 21, 1986

New Research Grant Awards

October 18, 1974

Scientific Process

September 25, 1998

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983